PGF1alpha

Pgf1alpha is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 970 references associated with PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for PGF1alpha

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGF1alpha

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 | Total 39

NCBI Entrez Crosslinks

All references with PGF1alpha

Download all related citations
Per page 10 20 50 100 | Total 251
Authors Title Published Journal PubMed Link
Mao E et al. [Pancreatic ischemia: a continuous injury factor in acute necrotic pancreatitis]. 1997 Zhonghua Wai Ke Za Zhi pmid:10374521
Zhang JN [Interference of platelet-activating factor antagonist, BN50739 with the releasing of inflammatory mediators from anaphylactic lung of guinea pig]. 1992 Zhonghua Jie He He Hu Xi Za Zhi pmid:1339617
Silberbauer K et al. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity]. 1982 Z Kardiol pmid:6753382
Colahan PT et al. Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test. 2002 Vet. Ther. pmid:12050827
Grando SA et al. [The role of cellular immune reactions in the pathogenesis of pemphigus vulgaris]. 1988 Vestn Dermatol Venerol pmid:3176656
Chaialo PP et al. [Blood lipids and characteristics of free radical processes in specific classes of lipoproteins in rats in the early periods after gamma-radiation]. 1992 May-Jun Ukr. Biokhim. Zh. pmid:1440973
Coffman TM et al. Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts. 1988 Transplantation pmid:3125638
Tannenbaum JS et al. Prostaglandin synthesis associated with renal allograft rejection in the dog. 1984 Transplantation pmid:6374997
Lane NJ et al. Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation. 1994 Transplantation pmid:7809921
Hotter G et al. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. 1995 Transplantation pmid:7871573
Suckfüll MM et al. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. 1994 Transplantation pmid:8310518
Klassen DK et al. Effects of cyclosporine on human renal allograft renin and prostaglandin production. 1989 Transplantation pmid:2660347
Johnson BF et al. Urinary amylase and immunoreactive metabolites of thromboxane B2 and 6keto-prostaglandin F1 alpha in rat pancreatic allograft rejection. 1989 Transplant. Proc. pmid:2468239
Kanji VK et al. Vitamin E suppresses cyclosporine A-induced increase in the urinary excretion of arachidonic acid metabolites including F2-isoprostanes in the rat model. 1999 Transplant. Proc. pmid:10331052
Storck M et al. Influence of systemic cyclooxygenase inhibition with single-dose aspisol on kinetics of arachidonic acid metabolites in the venous effluate of transplanted kidney grafts in humans. 1996 Transplant. Proc. pmid:8644237
Yokoyama I et al. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. 1996 Transpl. Int. pmid:8748415
Saldeen P et al. Increased synthesis of thromboxane B2 and 6-keto-PGF1 alpha in hand veins from patients with deep venous thrombosis. 1983 Thromb. Res. pmid:6658723
Goldsmith JC and Kisker CT Thrombin - endothelial cell interactions: critical importance of endothelial cell vessel of origin. 1982 Jan 1-15 Thromb. Res. pmid:6801808
Jackson CA et al. A study of the stimulation of human venous prostacyclin synthesis by dipyridamole. 1982 Thromb. Res. pmid:6758183
Buchanan MR et al. Inhibition of arterial thrombosis and platelet function by nafazatrom. 1982 Thromb. Res. pmid:6758186